Reason reports back from Rejuvenation Startup Summit 2024
Fight Aging! - 13-May-2024A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Longevity Technology
Daily news and insights on research, investments and technologies on life extension
We bring together innovators and investors to commercialise the companies that will form the longevity economy.
There are already 100+ rejuvenation biotechs working on unique therapies and building R&D pipelines to increase healthspan and lifespan.
At the same time, all around the world, innovators are releasing nanobots, reprogramming nerve signals and applying AI to create exciting and scalable contributions to human Longevity.
Visit website: https://www.longevity.technology/
Details last updated 12-Sep-2019
Longevity Technology News
Longevity now & next: Key findings and investment trends in 2023
Longevity Technology - 15-Apr-2024Longevity.Technology releases its annual longevity investment report 2023
Big investors join First Longevity funding round
Longevity Technology - 16-Oct-2020Key investors raise funding to support longevity sector
Longevity Technology is also referenced in the following:
Longevity Megatrend by Phil Newman
18-Jan-2023
Phil talks about shaping the longevity industry at this Oxford Society of Ageing and Longevity event (FREE)
Longevity Technology Creations
Leveraging the power of senolytics to eliminate senescence cells
Longevity Technology discusses senescent cells with Steve Matheson, CEO of Combilytics (YouTube)
People at Longevity Technology
Articles sourced from Longevity Technology
AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost
Longevity Technology - 30-Jun-2025Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Juvena strikes $650m deal with lilly to tackle obesity
Longevity Technology - 11-Jun-2025AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition
Longevity Technology - 05-Jun-2025Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025Somite AI uses DeltaStem to speed up and scale stem cell engineering
BrightFocus Foundation fuels early research on aging diseases with $13m grants
Longevity Technology - 13-May-2025Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Rewriting the cell's code: HAYA’s mission to transform genomic medicine
Longevity Technology - 12-May-2025Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states
Hundred health acquires BellSant to supercharge AI longevity platform strapline:
Longevity Technology - 08-May-2025AI-driven health platform gears up for launch with cutting-edge longevity data
NewLimit secures $130m to accelerate epigenetic reprogramming for longevity
Longevity Technology - 06-May-2025The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan
A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025PhotoPharmics secures $6 million to advance its home-based Celeste device
Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025HepaRegeniX advances trials for a novel liver regeneration therapy
Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025It avoids common delivery problems and enters Phase 1 trials in 2025
Tribune Therapeutics secures 37m to tackle fibrosis at its source
Longevity Technology - 28-Mar-2025Scandinavian biotech targets fibrosis with novel scar-blocking therapies
Mito Health raised $4 million to grow its AI-powered health platform
Longevity Technology - 18-Mar-2025It uses blood tests to find early health risks and gives personalised advice
Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs
Longevity Technology - 12-Mar-2025Clinical trials are beginning, backed by major investors like Novo Holdings
Trimtech secures $31m to tackle neurodegenerative diseases
Longevity Technology - 06-Mar-2025Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Europe’s first 100m consumer health fund targets proactive care revolution
Longevity Technology - 18-Feb-2025naturalX backs startups reshaping wellness and prevention
Display all articles
